CivilnetModerna's COVID-19 vaccine candidate is due to enter phase 3 clinical trial in July. The company's Chairman Noubar Afeyan, who is also the founder of Flagship Pioneering, is cautiously optimistic about the speedy approach to vaccine development. He talks to CivilNet's Syuzanna Petrosyan about Moderna, his philanthropic activities, and his path from an immigrant teenager fleeing civil war to a successful science innovator.
Armenia’s Central Bank raises interest rates to 7%: THIS WEEK IN BUSINESS
Inside the dry fruit culture on Armenia’s southern border
Armenia’s top diplomat not concerned over U.S. election impact on TRIPP
EU official: Armenia’s European future does not depend on developments in Georgia
A post-midterm Trump presidency and the implications for Armenia
UAE Researchers Develop AI System to Monitor Marine Biodiversity in the Arabian Gulf